159 related articles for article (PubMed ID: 30523347)
1. Transmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling.
Wan Z; Shao X; Ji X; Dong L; Wei J; Xiong Z; Liu W; Qi H
Cell Mol Immunol; 2020 Feb; 17(2):143-152. PubMed ID: 30523347
[TBL] [Abstract][Full Text] [Related]
2. Inducible costimulator (ICOS) potentiates TCR-induced calcium flux by augmenting PLCγ1 activation and actin remodeling.
Leconte J; Bagherzadeh Yazdchi S; Panneton V; Suh WK
Mol Immunol; 2016 Nov; 79():38-46. PubMed ID: 27693916
[TBL] [Abstract][Full Text] [Related]
3. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
[TBL] [Abstract][Full Text] [Related]
4. Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.
Gigoux M; Lovato A; Leconte J; Leung J; Sonenberg N; Suh WK
Mol Immunol; 2014 May; 59(1):46-54. PubMed ID: 24486724
[TBL] [Abstract][Full Text] [Related]
5. Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.
Guedan S; Posey AD; Shaw C; Wing A; Da T; Patel PR; McGettigan SE; Casado-Medrano V; Kawalekar OU; Uribe-Herranz M; Song D; Melenhorst JJ; Lacey SF; Scholler J; Keith B; Young RM; June CH
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321369
[TBL] [Abstract][Full Text] [Related]
6. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.
Gigoux M; Shang J; Pak Y; Xu M; Choe J; Mak TW; Suh WK
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20371-6. PubMed ID: 19915142
[TBL] [Abstract][Full Text] [Related]
7. Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells.
Wyatt MM; Huff LW; Nelson MH; Neal LR; Medvec AR; Rangel Rivera GO; Smith AS; Rivera Reyes AM; Knochelmann HM; Riley JL; Lesinski GB; Paulos CM
Mol Ther; 2023 Jul; 31(7):2120-2131. PubMed ID: 37081789
[TBL] [Abstract][Full Text] [Related]
8. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells.
Vettermann C; Victor HP; Sun Y; Plewa C; Gupta S
J Immunol Methods; 2015 Sep; 424():14-9. PubMed ID: 25956037
[TBL] [Abstract][Full Text] [Related]
9. A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1.
Pedros C; Zhang Y; Hu JK; Choi YS; Canonigo-Balancio AJ; Yates JR; Altman A; Crotty S; Kong KF
Nat Immunol; 2016 Jul; 17(7):825-33. PubMed ID: 27135603
[TBL] [Abstract][Full Text] [Related]
10. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
[TBL] [Abstract][Full Text] [Related]
11. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.
Cuevas B; Lu Y; Watt S; Kumar R; Zhang J; Siminovitch KA; Mills GB
J Biol Chem; 1999 Sep; 274(39):27583-9. PubMed ID: 10488096
[TBL] [Abstract][Full Text] [Related]
12. The kinase Itk and the adaptor TSAd change the specificity of the kinase Lck in T cells by promoting the phosphorylation of Tyr192.
Granum S; Sundvold-Gjerstad V; Gopalakrishnan RP; Berge T; Koll L; Abrahamsen G; Sørlie M; Spurkland A
Sci Signal; 2014 Dec; 7(355):ra118. PubMed ID: 25492967
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice.
Li J; Heinrichs J; Leconte J; Haarberg K; Semple K; Liu C; Gigoux M; Kornete M; Piccirillo CA; Suh WK; Yu XZ
J Immunol; 2013 Jul; 191(1):200-7. PubMed ID: 23729441
[TBL] [Abstract][Full Text] [Related]
14. Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8
Peng C; Huggins MA; Wanhainen KM; Knutson TP; Lu H; Georgiev H; Mittelsteadt KL; Jarjour NN; Wang H; Hogquist KA; Campbell DJ; Borges da Silva H; Jameson SC
Immunity; 2022 Jan; 55(1):98-114.e5. PubMed ID: 34932944
[TBL] [Abstract][Full Text] [Related]
15. ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse.
Fos C; Salles A; Lang V; Carrette F; Audebert S; Pastor S; Ghiotto M; Olive D; Bismuth G; Nunès JA
J Immunol; 2008 Aug; 181(3):1969-77. PubMed ID: 18641334
[TBL] [Abstract][Full Text] [Related]
16. Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling.
Gao X; Gigoux M; Yang J; Leconte J; Yang X; Suh WK
PLoS One; 2012; 7(12):e52657. PubMed ID: 23285133
[TBL] [Abstract][Full Text] [Related]
17. Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond.
Panneton V; Chang J; Witalis M; Li J; Suh WK
Immunol Rev; 2019 Sep; 291(1):91-103. PubMed ID: 31402504
[TBL] [Abstract][Full Text] [Related]
18. ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain.
O'Brien CA; Harris TH
PLoS One; 2020; 15(1):e0228251. PubMed ID: 31978191
[TBL] [Abstract][Full Text] [Related]
19. ICOS is required for the generation of both central and effector CD4(+) memory T-cell populations following acute bacterial infection.
Marriott CL; Carlesso G; Herbst R; Withers DR
Eur J Immunol; 2015 Jun; 45(6):1706-15. PubMed ID: 25754933
[TBL] [Abstract][Full Text] [Related]
20. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
Front Immunol; 2021; 12():786680. PubMed ID: 34925367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
